18 Jul Radiation Control releases latest FAQs
14 July 2022 Radiation Control has released their latest FAQs for: X-RaysInspectorateRadionuclides ...
Author: Ntokozo Msiza
28 Jun Health Product literacy top of mind as SAHPRA announces online medicines directory
28 June 2022 The South African Health Products Authority (SAHPRA) is pleased to announce the launch of an Over the Counter (OTC) Online Medicines’ Directory for South African consumers and healthcare professionals. The domain name is https://medsinfo.sahpra.org.za and the portal is available on the SAHPRA website. The...
27 May Update: SAHPRA Statement on the ANHP Judgement
27 May 2022 Embargo: Immediate release On 7 May 2022, the South African Health Products Regulatory Authority (SAHPRA) published a statement indicating that it would join the Minister of Health in approaching the Constitutional Court for leave to appeal the Supreme Court of Appeal (SCA) judgement...
17 May Regulatory experts from African countries visit the Paul-Ehrlich-Institut to discuss future cooperation with vaccine experts
17 May 2022 At a four-day meeting at the Paul-Ehrlich-Institut, representatives of the regulatory authorities in Ghana (Food and Drugs Authority, FDA), Rwanda (Food and Drugs Authority, FDA), South Africa (South African Health Products Regulatory Authority, SAHPRA) and Senegal (Agence sénégalaise de Réglementation Pharmaceutique, ARP) discussed future cooperation with vaccine...
08 Apr SAHPRA CT Office Relocation
08 April 2022 The South African Health Products Regulatory Authority (SAHPRA) office in Cape Town has relocated from Bellville to Tyger Valley. The new office will be located at: North BlockAvanti Towers Office Park35 Carl Cronje DriveTyger Falls The new office will be accessible from Monday, 11 April 2022. We...
08 Apr SAHPRA Responds to claims that hawkers are selling illicit medication in Cape Town
08 April 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) remains committed in protecting the public from the supply of counterfeit and substandard medicines. Following the media report by eNCA claiming that some hawkers in Cape Town were illegally selling medicines, SAHPRA worked...
31 Mar SAHPRA assigns a non-compliant rating to the Emergent BioSolutions COVID-19 facility
31 March 2022 SAHPRA has assigned a non-compliant rating to the Emergent BioSolutions COVID-19 facility based on new data received. This was following a collaborative inspection which was conducted both onsite and via remote inspection. This means that SAHPRA will not accept any drug products or...
11 Mar SAHPRA clarifies the risks and benefits of the Pfizer Comirnaty vaccine
11 March 2022 Embargo: Immediate release The South Africa Health Products Regulatory Authority (SAHPRA) has noted that a safety report in relation to the COVID-19 Pfizer Comirnaty vaccine directed to the United States Food and Drug Administration (FDA) has been distributed on various communication platforms in South...
17 Feb SAHPRA has authorised access to molnupiravir
17 February 2022 Embargo: Immediate release Until recently, the treatment options for patients with mild-to-moderate COVID-19 have been limited. New oral antiviral medicines are becoming available for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen and who are at risk of...
07 Feb SAHPRA registers two COVID-19 vaccines
adria Crehuet Cano via Unsplash...